Randomized phase II trial of adding carboplatin and/or bevacizumab to neoadjuvant weekly paclitaxel and dose-dense AC in triple-negative breast cancer
- Citation:
- J Clin Oncol vol 28 (15s) abstr TPS110
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2158
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- W. Sikov C. M. Perou M. Golshan D. Collyar D. A. Berry O. M. Hahn B. Singh C. A. Hudis E. P. Winer
- Networks:
- Study
- CALGB-40603
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: